Chirfi Guindo
Chief Marketing Officer; Director; EVP, Access, Policy & Comms · 7 filings · Latest: Jun 3, 2026
Beam Therapeutics Inc.
Merck & Co., Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
MRK | Chirfi Guindo | EVP, Access, Policy & Comms | Apr 29, 2026 | Option Exercise | $110.03 | 1,967 | $216.4K | 62,582.127 | |
MRK | CHIRFI GUINDO | — | Feb 9, 2026 | Proposed Sale | $118.41 | 20,000 | $2.4M | — | Feb 13 9:15 PM 144/A |
MRK | Chirfi Guindo | Chief Marketing Officer | Feb 12, 2026 | Sale | $121.46 | 10,000 | $1.2M | 60,615.127 | |
MRK | CHIRFI GUINDO | — | Feb 9, 2026 | Proposed Sale | $118.41 | 20,000 | $2.4M | — | |
MRK | Chirfi Guindo | Chief Marketing Officer | Feb 9, 2026 | Sale | $118.41 | 10,000 | $1.2M | 70,615.127 | |
MRK | Chirfi Guindo | Chief Marketing Officer | Feb 5, 2026 | Sale | $121.88 | 20,000 | $2.4M | 80,615.127 | |
MRK | CHIRFI GUINDO | — | Feb 5, 2026 | Proposed Sale | $121.88 | 20,000 | $2.4M | — |